Listed by the USPTO as ROBINSON, MIKHAIL O'DONNEL
Tech Center 1600 • Art Units: 1613 1627 1629
This examiner grants 58% of resolved cases
ROBINSON, MIKHAIL O'DONNEL is a USPTO patent examiner in Tech Center 1600 and art unit 1613. The record covers 132 resolved cases, with a 58.3% allowance rate. Interviews are associated with a 43.1% lift in allowance outcomes. The median time to allowance is 1228 days, indicating that prosecution in this docket may require sustained attention over an extended period.
The listed applicants include Board of Regents of the University of Texas System, The Board of Trustees of the Leland Stanford Junior University, and Bayer Aktiengesellschaft. Represented matters include BakerHostetler, Knobbe, Martens, Olson & Bear, LLP, and PANITCH SCHWARZE BELISARIO & NADEL LLP. Practitioners may find interview preparation particularly relevant given the recorded interview lift.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18893545 | SUBSTITUTED PYRAZOLO PIPERIDINE CARBOXYLIC ACIDS | Non-Final OA | Bayer Aktiengesellschaft |
| 18983692 | MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS OF USE THEREOF | Non-Final OA | Foresee Pharmaceuticals USA, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy58.3% of resolved applications examined by Mikhail O'Donnel Robinson were allowed (132 resolved cases), compared with 34.0% across Art Unit 1613 over the last five years.
This examiner's interview lift is +43.1 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Mikhail O'Donnel Robinson took 1,228 days on average from filing to allowance.
Mikhail O'Donnel Robinson examines applications in Art Unit 1613 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
